IgG-inspired, multivalent protein-DNA nanostructures for high-affinity, tunable, and reversible binding to biomolecular targets

This study presents an IgG-inspired, multivalent DNA nanostructure ("nano-synbody") that achieves high-affinity, tunable, and reversible binding to SARS-CoV-2 spike proteins by matching the target's geometry and valency, effectively neutralizing both wild-type and Omicron variants while demonstrating programmable assembly and disassembly.

The Gist

Imagine you are trying to catch a slippery, shape-shifting fish (the virus) with a net. Traditional fishing nets (like our natural antibodies) are great, but they have a few problems: they are all the same size, they can't easily change their shape to fit different fish, and once they catch something, they are stuck holding it until they naturally let go.

This paper describes a team of scientists who built a super-smart, programmable fishing net using DNA and tiny proteins. They call it a "Nano-Synbody."

Here is how it works, broken down into simple concepts:

1. The Problem: The Virus is a Master of Disguise

The SARS-CoV-2 virus has a "crown" of spikes on its surface. To infect a human cell, these spikes need to grab onto a specific door handle (the ACE2 receptor).

• The Old Way: Natural antibodies are like standard "Y-shaped" nets. They have two arms. If the virus mutates (changes its shape slightly, like the Omicron variant), the antibody might not fit anymore, and the virus escapes.
• The New Problem: Even if an antibody fits, it usually grabs just one spot. If the virus changes that one spot, the antibody loses its grip.

2. The Solution: A Custom-Built "Spider"

The scientists wanted to build a net that could:

• Be custom-sized to fit the virus perfectly.
• Grab the virus in three places at once (making it much harder to escape).
• Be able to let go on command if needed.

They used DNA nanotechnology to build this. Think of DNA not just as the code of life, but as a set of programmable Lego bricks that snap together to build specific shapes.

3. How the "Nano-Synbody" is Built

• The Body (The Fc Region): They built a rigid, three-helix bundle of DNA. Imagine this as the sturdy handle of a fishing rod. It's about the size of a natural antibody, so it's small enough to move around easily.
• The Arms (The Fab Regions): Attached to this handle are three flexible arms. At the end of each arm is a tiny, custom-designed protein (called LCB1) that acts like a magnet specifically designed to stick to the virus's spike.
• The Magic of Three: The virus's spikes are arranged in a triangle. The scientists used computer simulations to design their DNA handle so that the three arms are exactly the right distance apart to grab all three spikes of the virus simultaneously.

4. Why "Three Arms" is Better Than One

Imagine trying to hold onto a slippery bar with one hand. It's hard. Now imagine grabbing it with three hands at once. It's much harder to let go.

• The Results: When the scientists tested their "one-armed" version, it worked okay on the original virus but failed completely against the Omicron variant (which had mutated).
• The Power of Three: When they used the three-armed version, it grabbed the Omicron virus with incredible strength (100 times stronger than the single arm). It was like upgrading from a weak magnet to a super-magnet just by adding more arms.

5. The "Remote Control" Feature (Reversibility)

This is the coolest part. Usually, once an antibody grabs a virus, it stays stuck. But because this net is made of DNA, the scientists can use a molecular "remote control" to make it let go.

• They added special "toeholds" (little DNA tags) to the arms.
• By adding a specific "invader strand" of DNA, they can trigger a reaction that snips off one, two, or all three arms.
• The Analogy: It's like having a robot arm that can pick up a box, move it, and then, with a specific code, instantly release the box and retract its fingers. This allows them to "turn off" the blocker if they want to reactivate the virus (for research) or to release the virus from a sensor.

6. What This Means for the Future

• Rescuing Bad Binders: Even if a protein is a weak fighter against a mutated virus, putting three of them on this DNA scaffold makes them a super-fighter.
• Customization: If a new virus appears, scientists don't need to wait years to grow new antibodies. They can just redesign the DNA "Lego" instructions to match the new virus's shape and snap it together quickly.
• Nanobots: This technology could lead to tiny robots that can grab specific proteins, move them to a different location inside a cell, and then let them go, acting like microscopic construction workers.

In a nutshell: The scientists built a programmable, three-armed DNA spider that can grab a virus much tighter than nature's own antibodies, especially against tricky mutated versions. Best of all, they can use a DNA "remote control" to make the spider let go whenever they want.

Technical Summary

1. Problem Statement

Traditional immunoglobulin G (IgG) antibodies are the gold standard for high-affinity, specific binding but suffer from inherent limitations:

• Fixed Geometry: Their "Y" shape and inter-arm spacing (~10–15 nm) are biologically fixed, making it difficult to match targets with different epitope distances (e.g., the SARS-CoV-2 spike trimer has RBDs spaced ~7 nm apart).
• Irreversibility: Antibody binding is typically irreversible, limiting their use in applications requiring dynamic release or "on-demand" deactivation of a target.
• Vulnerability to Mutations: Monovalent binding sites are susceptible to mutational escape (e.g., Omicron variants), where single amino acid changes can drastically reduce binding affinity.
• Lack of Tunability: It is difficult to dynamically adjust the valency (number of binding arms) of an antibody to optimize avidity for specific targets.

The authors aimed to create a synthetic antibody ("nano-synbody") that mimics the IgG structure but utilizes DNA nanotechnology to offer programmable geometry, tunable valency, and reversible binding.

2. Methodology

The research employed an integrated computational-experimental pipeline:

• Computational Design & Simulation:

  • Used a coarse-grained oxDNA-ANM (anisotropic network model) simulation pipeline to design a DNA nanostructure.
  • The goal was to create a rigid core (Fc-mimetic) linked to flexible arms (Fab-mimetic) that could span the ~7 nm distance between the three Receptor Binding Domains (RBDs) of the SARS-CoV-2 spike trimer.
  • Simulations optimized the rigidity of the core and the flexibility of the linkers to ensure the structure could bind multiple conformations of the spike protein (e.g., "all-up" or "two-up/one-down" states) without significant entropic penalty.

• Nanostructure Synthesis:

  • Scaffold: A three-helix bundle (3HB) DNA nanostructure was assembled from six oligonucleotide strands. This served as the rigid "Fc" core.
  • Binding Arms: The 3HB was designed with 1, 2, or 3 single-stranded DNA arms.
  • Protein Conjugation: A de novo designed mini-protein binder (LCB1, 7 kDa) targeting the SARS-CoV-2 RBD was conjugated to a DNA handle via a cysteine-maleimide chemistry (SMCC linker).
  • Assembly: The LCB1-DNA conjugates were hybridized to the 3HB scaffold to create 1-arm, 2-arm, and 3-arm nano-synbodies.

• Reversibility Mechanism:

  • The DNA arms were extended with unique toehold domains.
  • Toehold-mediated strand displacement was used to programmatically remove specific arms by adding complementary "invader" strands, allowing the system to switch valency from trivalent $\to$ bivalent $\to$ monovalent $\to$ zero-valent.

• Characterization:

  • Surface Plasmon Resonance (SPR): Measured binding affinity ($K_D$) against Wild-Type (WT) and Omicron (BA.1) spike proteins.
  • Pseudovirus Neutralization: Assayed the ability of the nano-synbodies to block infection in HEK 293T cells expressing hACE2.
  • Negative-Stain TEM (nsTEM): Visualized the 3-arm nano-synbody bound to the Omicron spike trimer to confirm structural integrity and trivalent binding.

3. Key Contributions

• IgG-Mimetic DNA Scaffold: Successfully engineered a DNA nanostructure that mimics the IgG "Y" shape but is tunable to match the specific ~7 nm spacing of the SARS-CoV-2 spike trimer, rather than the ~15 nm spacing of natural IgGs.
• Systematic Valency Tuning: Demonstrated the ability to construct and compare mono-, bi-, and trivalent versions of the same synthetic antibody to isolate the effects of multivalency.
• Reversible Binding: Pioneered the use of toehold-mediated strand displacement to dynamically remove binding arms after the complex has formed, effectively turning a high-affinity binder into a low-affinity one on demand.
• Rescue of Weak Binders: Showed that multivalency can "rescue" a monovalent binder that has lost efficacy against a mutant variant (Omicron) due to the avidity effect.

4. Key Results

• Binding Affinity (SPR):

  • Monovalent (1-arm): $K_D \approx 1.2$ nM for WT; no detectable binding for Omicron.
  • Trivalent (3-arm): $K_D \approx 11.2$ pM for WT (~100-fold enhancement over monovalent).
  • Omicron Variant: The 3-arm structure achieved a $K_D$ of 95 pM against Omicron BA.1, whereas the monovalent binder was ineffective ($K_D > 100$ nM). This represents a >1000-fold enhancement via multivalency.
  • The 2-arm structure showed intermediate affinity, confirming a dose-dependent relationship between valency and affinity.

• Virus Neutralization:

  • The 3-arm nano-synbody effectively neutralized pseudoviruses bearing WT and Omicron (BA.1, BA.2, BA.4/5) spikes.
  • For Omicron BA.1, the 3-arm structure had an $IC_{50}$ of 548 pM, compared to 17.4 nM for the 1-arm structure (~30-fold improvement).
  • For Omicron BA.4, the 1-arm structure failed to inhibit infection even at high concentrations, while the 3-arm structure achieved an $IC_{50}$ of 1.3 nM.

• Structural Confirmation (TEM):

  • nsTEM reconstruction of the 3-arm nano-synbody bound to the Omicron spike trimer confirmed that all three arms successfully engaged the three RBDs in the "up" conformation, matching the computational design.

• Reversibility:

  • Adding invader strands successfully displaced 1, 2, or 3 arms.
  • Displacing arms converted the high-affinity 3-arm complex back to a low-affinity state. For Omicron, this caused the complex to dissociate completely, while the WT complex remained bound (due to the intrinsic high affinity of the remaining monovalent LCB1), demonstrating programmable release.

5. Significance

• Overcoming Mutational Escape: This work proves that DNA-based multivalency can compensate for the loss of affinity caused by viral mutations, offering a robust strategy against rapidly evolving pathogens like SARS-CoV-2.
• Dynamic Control: The ability to reversibly switch valency transforms the nano-synbody from a static binder into a programmable nanorobot. This enables applications such as:
  • "Turning off" target blocking to activate a protein on demand.
  • Releasing captured targets from a surface.
  • Sequential staining and imaging without permanent binding.
• Modular Platform: The design is highly modular. The DNA scaffold can be easily reconfigured to target different proteins, display different ligands (aptamers, peptides, other proteins), or be scaled up to higher-order valencies (e.g., IgM-mimetics).
• Future Applications: Beyond therapeutics, these structures could serve as "nanoscale gripper arms" for manipulating single molecules, integrating with DNA walkers or mechanical devices for precise spatial control in nanofabrication and synthetic biology.

In summary, the paper presents a successful proof-of-concept for computational design of protein-DNA hybrid nanostructures that outperform natural antibodies in tunability and reversibility, while leveraging multivalency to achieve ultra-high affinity against challenging viral variants.